Deadly Superbugs Win as Wall Street Flees Makers of Antibiotics

(Bloomberg) -- Four years ago, antibiotics developer Tetraphase Pharmaceuticals Inc. had a market value of almost $2 billion. Now its shares trade for about 70 cents as investors flee the market fo...

Bloomberg Quint

Add BloombergQuint App to Home screen.